Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Cumberland Pharmaceuticals, Inc. (CPIX) A Good Stock To Buy?

Page 1 of 2

The market has been volatile as the Federal Reserve winds down its easy money policies. Small cap stocks have been hit hard as a result, as the Russell 2000 ETF (IWM) has underperformed the larger S&P 500 ETF (SPY) by more than 14 percentage points between June 25th and the end of October. SEC filings and hedge fund investor letters indicate that the smart money seems to be paring back their overall long exposure, and the funds’ movements is one of the reasons why the major indexes have retraced. In this article, we analyze what the smart money thinks of Cumberland Pharmaceuticals, Inc. (NASDAQ:CPIX) and find out how it is affected by hedge funds’ moves.

Cumberland Pharmaceuticals, Inc. (NASDAQ:CPIX) shares haven’t seen a lot of action during the third quarter. Overall, hedge fund sentiment was unchanged. The stock was in 5 hedge funds’ portfolios at the end of the third quarter of 2015. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as Tremor Video Inc (NYSE:TRMR), Trillium Therapeutics Inc. (NASDAQ:TRIL), and RADCOM Ltd. (NASDAQ:RDCM) to gather more data points.

Follow Cumberland Pharmaceuticals Inc (NASDAQ:CPIX)
Trade (NASDAQ:CPIX) Now!

In the financial world there are plenty of metrics stock market investors use to appraise stocks. A duo of the most useful metrics are hedge fund and insider trading interest. Our experts have shown that, historically, those who follow the top picks of the best investment managers can outperform the broader indices by a healthy margin (see the details here).

Now, let’s take a look at the latest action regarding Cumberland Pharmaceuticals, Inc. (NASDAQ:CPIX).

How are hedge funds trading Cumberland Pharmaceuticals, Inc. (NASDAQ:CPIX)?

According to Insider Monkey’s hedge fund database, Millennium Management, managed by Israel Englander, holds the most valuable position in Cumberland Pharmaceuticals, Inc. (NASDAQ:CPIX). Millennium Management has an $3.6 million position in the stock, comprising less than 0.1% of its 13F portfolio. On Millennium Management’s heels is Renaissance Technologies, managed by Jim Simons, which holds an $1.1 million position; less than 0.1% of its 13F portfolio is allocated to the stock. Remaining peers that hold long positions include Peter Muller’s PDT Partners, and Chuck Royce’s Royce & Associates.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!